Association between vascular endothelial dysfunction and the inflammatory marker neopterin in patients with classic

Hekma Saad Farghaly1, Kotb Abbass Metwalley1, Duaa Mohamed Raafat1

  • 1Department of Pediatrics, Faculty of Medicine, Assiut University, Asyut, Egypt.

Atherosclerosis
|June 6, 2021
PubMed

Insights

Congenital adrenal hyperplasia (CAH) patients exhibit endothelial dysfunction, an early vascular issue. This dysfunction is linked to elevated neopterin (NP) levels, indicating inflammation

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Immunology

Background:

  • Congenital adrenal hyperplasia (CAH) patients face heightened risks of cardiometabolic complications.
  • Endothelial dysfunction is a recognized early vascular abnormality in CAH.

Purpose of the Study:

  • To assess vascular endothelial dysfunction in CAH patients.
  • To investigate the association between endothelial dysfunction and serum neopterin (NP) levels in CAH.

Main Methods:

  • 40 CAH patients and 40 healthy controls were compared.
  • Vascular ultrasound measured brachial artery flow-mediated dilation (FMD%) and carotid intima-media thickness (CA-IMT).
  • Serum neopterin (NP) levels, HOMA-IR, and hs-CRP were analyzed.

Main Results:

  • CAH patients showed significantly lower FMD% and higher NP levels compared to controls.
  • FMD% was significantly correlated with NP, hs-CRP, HOMA-IR, and CA-IMT.
  • Neopterin (NP) emerged as the strongest independent predictor of FMD%.

Conclusions:

  • CAH patients exhibit endothelial dysfunction, an early stage of vascular disease.
  • Elevated NP levels are significantly associated with endothelial dysfunction in CAH.
  • Inflammation, indicated by NP, likely plays a key role in CAH-related vascular damage.
Abstract